Stefan Laufer is Professor and Chairman for Pharmaceutical/Medicinal Chemistry at Tuebingen University. He received his degrees from Regensburg University. After 10 years in Pharmaceutical Industry he joined in 1999 Tuebingen University as Chairman Pharm./Med. Chemistry. His research interests are anti-inflammatory and cancer drug discovery with various eicosanoid (COX-1,2,3, LOXs, mPGES1, cPLA2) and protein kinase targets (e.g. p38s, JAKs, JNKs, CK1s, mtEGRFs, BTK, ATM, ATR, AurKa). Prof. Laufer is co-founder of the ICEPHA (Interfaculty Center for Pharmacogenomics and Drug Research), TüCADD, Tuebingen Center for Academic Drug Discovery and is co-founder of two start-up companies. He served the community in various positions (e.g. President German Pharmaceutical Society 2016-2019, Boardmember MedChem Division, German Chemical Society 2012-2023). Prof. Laufer is associate editor of the ACS Journal of Medicinal Chemistry, authored more than 735 publications, 17 books/bookchapters and is inventor in 54 patent families with 414 national applications.

5 compounds from his lab made it to first into human studies.
He received the “Mannich-Medal” of the German Pharmaceutical Society (DPhG) in 2024 and the “Stolz-Award” of the German Chemical Society (GDCh) in 2025